scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences
scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company focused on cardiorenal healthcare innovation, has announced its participation in two major investor conferences in March 2025. John Tucker, President and CEO, will represent the company at both events.
The scheduled appearances include:
- A fireside chat at the 45th Annual TD Cowen Healthcare Conference on March 5 at 11:10AM ET
- A corporate presentation at the Leerink Partners 2025 Global Healthcare Conference on March 11 at 2:20PM ET
Both presentations will be accessible via webcast through the company's website under the Investor Relations section.
scPharmaceuticals (Nasdaq: SCPH), un'azienda farmaceutica focalizzata sull'innovazione nella salute cardiorenale, ha annunciato la sua partecipazione a due importanti conferenze per investitori a marzo 2025. John Tucker, Presidente e CEO, rappresenterà l'azienda in entrambi gli eventi.
Le apparizioni programmate includono:
- Un incontro informale al 45° Annuale TD Cowen Healthcare Conference il 5 marzo alle 11:10 ET
- Una presentazione aziendale al Leerink Partners 2025 Global Healthcare Conference l'11 marzo alle 14:20 ET
Entrambe le presentazioni saranno accessibili tramite webcast attraverso il sito web dell'azienda nella sezione Relazioni con gli Investitori.
scPharmaceuticals (Nasdaq: SCPH), una compañía farmacéutica enfocada en la innovación en salud cardiorenal, ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025. John Tucker, presidente y CEO, representará a la compañía en ambos eventos.
Las apariciones programadas incluyen:
- Una charla informal en la 45ª Conferencia Anual de Salud TD Cowen el 5 de marzo a las 11:10 AM ET
- Una presentación corporativa en la Conferencia Global de Salud Leerink Partners 2025 el 11 de marzo a las 2:20 PM ET
Ambas presentaciones estarán disponibles a través de un webcast en el sitio web de la compañía en la sección de Relaciones con Inversores.
scPharmaceuticals (Nasdaq: SCPH)는 심장 신장 건강 혁신에 중점을 둔 제약 회사로, 2025년 3월에 두 개의 주요 투자자 회의에 참여할 것이라고 발표했습니다. John Tucker 사장 겸 CEO가 두 행사에서 회사를 대표할 것입니다.
예정된 발표 내용은 다음과 같습니다:
- 3월 5일 오전 11시 10분 ET에 열리는 제45회 연례 TD Cowen 헬스케어 회의에서의 대화
- 3월 11일 오후 2시 20분 ET에 열리는 Leerink Partners 2025 글로벌 헬스케어 회의에서의 기업 발표
두 발표 모두 회사 웹사이트의 투자자 관계 섹션을 통해 웹캐스트로 시청할 수 있습니다.
scPharmaceuticals (Nasdaq: SCPH), une entreprise pharmaceutique axée sur l'innovation en santé cardiorénale, a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025. John Tucker, président et directeur général, représentera l'entreprise lors des deux événements.
Les apparitions programmées comprennent:
- Une discussion informelle lors de la 45e Conférence Annuelle TD Cowen sur la Santé le 5 mars à 11h10 ET
- Une présentation d'entreprise lors de la Conférence Mondiale sur la Santé Leerink Partners 2025 le 11 mars à 14h20 ET
Les deux présentations seront accessibles par webcast via le site web de l'entreprise dans la section Relations avec les Investisseurs.
scPharmaceuticals (Nasdaq: SCPH), ein Pharmaunternehmen, das sich auf Innovationen im Bereich der kardiovaskulären Gesundheit konzentriert, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt. John Tucker, Präsident und CEO, wird das Unternehmen bei beiden Veranstaltungen vertreten.
Die geplanten Auftritte umfassen:
- Ein informelles Gespräch auf der 45. jährlichen TD Cowen Gesundheitskonferenz am 5. März um 11:10 Uhr ET
- Eine Unternehmenspräsentation auf der Leerink Partners 2025 Global Healthcare Conference am 11. März um 14:20 Uhr ET
Beide Präsentationen werden über einen Webcast auf der Unternehmenswebsite im Bereich Investor Relations zugänglich sein.
- None.
- None.
BURLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that John Tucker, President and Chief Executive Officer, will present at the following upcoming investor conferences:
- 45th Annual TD Cowen Healthcare Conference: Fireside chat on Wednesday, March 5 at 11:10AM ET.
- Leerink Partners 2025 Global Healthcare Conference: Corporate presentation on Tuesday, March 11 at 2:20PM ET.
A webcast of the presentations can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scPharmaceuticals.com.
About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
Investors:
Nick Colangelo
Gilmartin Group, 339-225-1047
Nick@GilmartinIR.com
FAQ
When is scPharmaceuticals (SCPH) presenting at the TD Cowen Healthcare Conference in 2025?
What investor conferences is SCPH attending in March 2025?
When is SCPH's presentation at the Leerink Partners Conference?
How can investors access SCPH's conference presentations?
